Correlations between serum lipid and Ki-67 levels in different breast cancer molecular subcategories

• Published in: Oncology letters Vol. 25; no. 2; p. 53
• Main Authors: Sun, Xi-Bo, Liu, Wen-Wen, Wang, Bing, Yang, Zhen-Peng, Tang, Hua-Zhen, Lu, Shuai, Wang, Yu-Ying, Qu, Jin-Xiu, Rao, Ben-Qiang
• Format: Journal Article
• Language: English
• Published: Greece Spandidos Publications 01.02.2023; Spandidos Publications UK Ltd
• Subjects: Antigens; Blood lipids; Body mass index; Breast cancer; Cardiovascular disease; Care and treatment; Cell growth; Epidermal growth factor; Estrogen; Health aspects; Lipids; Low density lipoproteins; Medical prognosis; Medical research; Medicine, Experimental; Menopause; Oncology; Progesterone; Triglycerides; Women; Womens health; Canada; China; breast cancer; molecular subcategories; serum lipids; prognosis; Ki-67 level
• ISSN: 1792-1074; 1792-1082
• DOI: 10.3892/ol.2022.13639

Breast cancer has the highest incidence rate among all cancer types worldwide, seriously threatening women's health. The present retrospective study explored differences in serum lipid contents in different breast cancer (BC) subcategories and their correlation with Ki-67 expression levels in patients with invasive BC with the aim of identifying novel diagnostic and prognostic indicators for personalized BC treatment. The study included 170 patients diagnosed with BC who were diagnosed with invasive BC by postoperative pathological examination. Data on patient age, body mass index and menopausal status were collected, in addition to estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2 (HER2) and antigen Ki-67 expression levels and pathological tumor type. Preoperative circulating lipid levels, specifically the levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglycerides (TG) and apolipoproteins A1 (ApoA1) and B (ApoB) were also obtained. Molecular subcategories of BC were grouped based on their immunohistochemistry. Differences in serum lipid levels between the groups were assessed, and correlations between serum lipid and Ki-67 expression levels were explored. While TC, LDL-C, HDL-C and ApoA1 levels differed significantly among molecular subcategories. TG and ApoB levels did not. Circulating TC and LDL-C levels were considerably higher in patients with triple-negative BC (TNBC) and HER2-positive [hormone receptor (HR)-negative] BC than in those with luminal A and B (HER2-negative) BC. Serum HDL-C levels were significantly diminished in the TNBC and HER2-positive (HR-negative) groups compared with the luminal A and B (HER2-negative) groups. ApoA1 levels were significantly reduced in cases of TNBC and HER2-positive (HR-negative) BC compared with luminal A and B BC. Ki-67 expression levels were positively correlated with circulating TC and LDL-C levels and inversely correlated with circulating HDL-C and ApoA1 levels but exhibited no correlation with serum ApoB and TG levels. The results indicate that elevated TC and LDL-C levels and diminished HDL-C and ApoA1 levels were high-risk factors in patients with TNBC and HER2-positive (HR-negative) BC, but not patients with luminal subcategories of BC. Abnormal serum lipid levels were correlated with Ki-67 expression levels, with elevated circulating TC and LDL-C levels and reduced circulating HDL-C and ApoA1 levels indicating a poor prognosis in patients with BC.